This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
European health officials are calling for urgent action as a series of new reports shows a mixed picture on antibiotic consumption and antimicrobial resistance (AMR).
Among the reports released by the European Centre for Disease Prevention and Control (ECDC) was the annual epidemiologic report on antibiotic consumption in European Union/European Economic Area (EU/EEA) countries, which shows a 5% decline in human antibiotic use compared with the 2019 baseline. There was also a small increase in the proportion of World Health Organization–designated first-line antibiotics being used for common infections—a measure of appropriate antibiotic use.
But the drop in antibiotic consumption is far from the EU's 2030 target of a 20% reduction. And the proportion of first-line antibiotics being consumed (62.5%) is short of the 65% goal by 2030.
The targets were established by EU leaders in 2023 as part of the EU's One Health action plan on AMR, which is estimated to cause at least 35,000 deaths every year on the continent.
"We are still behind with several of the EU's 2030 targets to counter antimicrobial resistance," ECDC Director Pamela Rendi-Wagner, MD, said in a press release.
A report on AMR rates in EU/EEA countries shows that bloodstream infections caused by a major drug-resistant pathogen—methicillin-resistant Staphylococcus aureus—have fallen 19% since 2019. 4% and 72%, respectively, since 2019.
Source link







